Figure 3.
Random-effects model analysis of the relative risk of (A) head-up-tilt-induced syncope and (B) clinical syncope in patients with recurrent vasovagal syncope treated with midodrine or control therapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.